{"transactions":[{"id":884526,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-02-24T18:48:05.000Z","date":"2026-02-20","kind":"grant","planned":false,"acquired":true,"shares":12050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/12 of the total shares monthly beginning March 20, 2026 until the option is fully vested on February 20, 2027, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":12050,"derivative":{"exercise_price":17.64,"expiration_date":"2036-02-20","underlying":"Common Stock","underlying_shares":12050},"source":{"system":"sec-edgar","filing":"0001628280-26-011325","document":"wk-form4_1771976881.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000162828026011325/wk-form4_1771976881.xml","form_type":"4"}},{"id":1011297,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-30T20:22:58.000Z","date":"2025-10-30","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":848000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"As of immediately prior to and conditioned upon the occurrence of the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option to purchase Shares (each, an \"Option\") became fully vested and exercisable, and to the extent not exercised prior to the effective time of the Merger, was cancelled and converted into the right to receive (i) an amount in cash (without interest and subject to deduction for any required withholding taxes) equal to the product of (A) an amount equal to the excess of the Closing Amount over the exercise price per Share with respect to such Option and (B) the number of Shares subject to such Option plus (ii) one CVR with respect to each Share subject to such Option (the \"Option Consideration\"); provided, however, that if the exercise price per Share of any Option was equal to or greater than the Closing Amount, but less than $20.50 (any such option, an \"Out of the Money Option\"), [continues to Footnote 6]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"[Continues from Footnote 5] such Out of the Money Option was not entitled to any payment of the Closing Amount in respect thereof and each Out of the Money Option was converted into the right to receive the CVR included in the Option Consideration with respect to each Share underlying such Out of the Money Option and became entitled to receive, at each time a milestone payment becomes due and payable under the terms of the CVR Agreement, an amount in cash equal to the product of (i) the number of Shares subject to such Out of the Money Option, and (ii) the amount, if any, by which (A) the Closing Amount plus the applicable milestone payment plus any other milestone payment that previously became due and payable under the terms of the CVR Agreement exceeds (B) the exercise price per Share with respect to such Out of the Money Option plus the amounts, [continues to Footnote 7]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"[Continues from Footnote 6] if any, paid to such Option holder with respect to such CVR in respect of any milestone payments that previously became due and payable under the terms of the CVR Agreement; provided further, that any Option with an exercise price that was equal to or greater than $20.50, was cancelled immediately prior to the effective time of the Merger without the receipt of any payment of the Closing Amount or CVR in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":9.6,"expiration_date":"2035-02-01","underlying":"Common Stock","underlying_shares":848000},"source":{"system":"sec-edgar","filing":"0001193125-25-259054","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000119312525259054/ownership.xml","form_type":"4"}},{"id":1011296,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-30T20:22:58.000Z","date":"2025-10-30","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":605000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"As of immediately prior to and conditioned upon the occurrence of the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option to purchase Shares (each, an \"Option\") became fully vested and exercisable, and to the extent not exercised prior to the effective time of the Merger, was cancelled and converted into the right to receive (i) an amount in cash (without interest and subject to deduction for any required withholding taxes) equal to the product of (A) an amount equal to the excess of the Closing Amount over the exercise price per Share with respect to such Option and (B) the number of Shares subject to such Option plus (ii) one CVR with respect to each Share subject to such Option (the \"Option Consideration\"); provided, however, that if the exercise price per Share of any Option was equal to or greater than the Closing Amount, but less than $20.50 (any such option, an \"Out of the Money Option\"), [continues to Footnote 6]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"[Continues from Footnote 5] such Out of the Money Option was not entitled to any payment of the Closing Amount in respect thereof and each Out of the Money Option was converted into the right to receive the CVR included in the Option Consideration with respect to each Share underlying such Out of the Money Option and became entitled to receive, at each time a milestone payment becomes due and payable under the terms of the CVR Agreement, an amount in cash equal to the product of (i) the number of Shares subject to such Out of the Money Option, and (ii) the amount, if any, by which (A) the Closing Amount plus the applicable milestone payment plus any other milestone payment that previously became due and payable under the terms of the CVR Agreement exceeds (B) the exercise price per Share with respect to such Out of the Money Option plus the amounts, [continues to Footnote 7]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"[Continues from Footnote 6] if any, paid to such Option holder with respect to such CVR in respect of any milestone payments that previously became due and payable under the terms of the CVR Agreement; provided further, that any Option with an exercise price that was equal to or greater than $20.50, was cancelled immediately prior to the effective time of the Merger without the receipt of any payment of the Closing Amount or CVR in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":9.98,"expiration_date":"2034-02-01","underlying":"Common Stock","underlying_shares":605000},"source":{"system":"sec-edgar","filing":"0001193125-25-259054","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000119312525259054/ownership.xml","form_type":"4"}},{"id":1011295,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-30T20:22:58.000Z","date":"2025-10-30","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"As of immediately prior to and conditioned upon the occurrence of the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option to purchase Shares (each, an \"Option\") became fully vested and exercisable, and to the extent not exercised prior to the effective time of the Merger, was cancelled and converted into the right to receive (i) an amount in cash (without interest and subject to deduction for any required withholding taxes) equal to the product of (A) an amount equal to the excess of the Closing Amount over the exercise price per Share with respect to such Option and (B) the number of Shares subject to such Option plus (ii) one CVR with respect to each Share subject to such Option (the \"Option Consideration\"); provided, however, that if the exercise price per Share of any Option was equal to or greater than the Closing Amount, but less than $20.50 (any such option, an \"Out of the Money Option\"), [continues to Footnote 6]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"[Continues from Footnote 5] such Out of the Money Option was not entitled to any payment of the Closing Amount in respect thereof and each Out of the Money Option was converted into the right to receive the CVR included in the Option Consideration with respect to each Share underlying such Out of the Money Option and became entitled to receive, at each time a milestone payment becomes due and payable under the terms of the CVR Agreement, an amount in cash equal to the product of (i) the number of Shares subject to such Out of the Money Option, and (ii) the amount, if any, by which (A) the Closing Amount plus the applicable milestone payment plus any other milestone payment that previously became due and payable under the terms of the CVR Agreement exceeds (B) the exercise price per Share with respect to such Out of the Money Option plus the amounts, [continues to Footnote 7]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"[Continues from Footnote 6] if any, paid to such Option holder with respect to such CVR in respect of any milestone payments that previously became due and payable under the terms of the CVR Agreement; provided further, that any Option with an exercise price that was equal to or greater than $20.50, was cancelled immediately prior to the effective time of the Merger without the receipt of any payment of the Closing Amount or CVR in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":14.7,"expiration_date":"2033-02-09","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001193125-25-259054","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000119312525259054/ownership.xml","form_type":"4"}},{"id":1011294,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-30T20:22:58.000Z","date":"2025-10-30","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":220000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"As of immediately prior to and conditioned upon the occurrence of the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option to purchase Shares (each, an \"Option\") became fully vested and exercisable, and to the extent not exercised prior to the effective time of the Merger, was cancelled and converted into the right to receive (i) an amount in cash (without interest and subject to deduction for any required withholding taxes) equal to the product of (A) an amount equal to the excess of the Closing Amount over the exercise price per Share with respect to such Option and (B) the number of Shares subject to such Option plus (ii) one CVR with respect to each Share subject to such Option (the \"Option Consideration\"); provided, however, that if the exercise price per Share of any Option was equal to or greater than the Closing Amount, but less than $20.50 (any such option, an \"Out of the Money Option\"), [continues to Footnote 6]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"[Continues from Footnote 5] such Out of the Money Option was not entitled to any payment of the Closing Amount in respect thereof and each Out of the Money Option was converted into the right to receive the CVR included in the Option Consideration with respect to each Share underlying such Out of the Money Option and became entitled to receive, at each time a milestone payment becomes due and payable under the terms of the CVR Agreement, an amount in cash equal to the product of (i) the number of Shares subject to such Out of the Money Option, and (ii) the amount, if any, by which (A) the Closing Amount plus the applicable milestone payment plus any other milestone payment that previously became due and payable under the terms of the CVR Agreement exceeds (B) the exercise price per Share with respect to such Out of the Money Option plus the amounts, [continues to Footnote 7]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"[Continues from Footnote 6] if any, paid to such Option holder with respect to such CVR in respect of any milestone payments that previously became due and payable under the terms of the CVR Agreement; provided further, that any Option with an exercise price that was equal to or greater than $20.50, was cancelled immediately prior to the effective time of the Merger without the receipt of any payment of the Closing Amount or CVR in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":4.44,"expiration_date":"2032-02-16","underlying":"Common Stock","underlying_shares":220000},"source":{"system":"sec-edgar","filing":"0001193125-25-259054","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000119312525259054/ownership.xml","form_type":"4"}},{"id":1011293,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-30T20:22:58.000Z","date":"2025-10-30","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":203750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"As of immediately prior to and conditioned upon the occurrence of the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option to purchase Shares (each, an \"Option\") became fully vested and exercisable, and to the extent not exercised prior to the effective time of the Merger, was cancelled and converted into the right to receive (i) an amount in cash (without interest and subject to deduction for any required withholding taxes) equal to the product of (A) an amount equal to the excess of the Closing Amount over the exercise price per Share with respect to such Option and (B) the number of Shares subject to such Option plus (ii) one CVR with respect to each Share subject to such Option (the \"Option Consideration\"); provided, however, that if the exercise price per Share of any Option was equal to or greater than the Closing Amount, but less than $20.50 (any such option, an \"Out of the Money Option\"), [continues to Footnote 6]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"[Continues from Footnote 5] such Out of the Money Option was not entitled to any payment of the Closing Amount in respect thereof and each Out of the Money Option was converted into the right to receive the CVR included in the Option Consideration with respect to each Share underlying such Out of the Money Option and became entitled to receive, at each time a milestone payment becomes due and payable under the terms of the CVR Agreement, an amount in cash equal to the product of (i) the number of Shares subject to such Out of the Money Option, and (ii) the amount, if any, by which (A) the Closing Amount plus the applicable milestone payment plus any other milestone payment that previously became due and payable under the terms of the CVR Agreement exceeds (B) the exercise price per Share with respect to such Out of the Money Option plus the amounts, [continues to Footnote 7]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"[Continues from Footnote 6] if any, paid to such Option holder with respect to such CVR in respect of any milestone payments that previously became due and payable under the terms of the CVR Agreement; provided further, that any Option with an exercise price that was equal to or greater than $20.50, was cancelled immediately prior to the effective time of the Merger without the receipt of any payment of the Closing Amount or CVR in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":23.01,"expiration_date":"2031-02-05","underlying":"Common Stock","underlying_shares":203750},"source":{"system":"sec-edgar","filing":"0001193125-25-259054","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000119312525259054/ownership.xml","form_type":"4"}},{"id":1011292,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-30T20:22:58.000Z","date":"2025-10-30","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":170000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"As of immediately prior to and conditioned upon the occurrence of the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option to purchase Shares (each, an \"Option\") became fully vested and exercisable, and to the extent not exercised prior to the effective time of the Merger, was cancelled and converted into the right to receive (i) an amount in cash (without interest and subject to deduction for any required withholding taxes) equal to the product of (A) an amount equal to the excess of the Closing Amount over the exercise price per Share with respect to such Option and (B) the number of Shares subject to such Option plus (ii) one CVR with respect to each Share subject to such Option (the \"Option Consideration\"); provided, however, that if the exercise price per Share of any Option was equal to or greater than the Closing Amount, but less than $20.50 (any such option, an \"Out of the Money Option\"), [continues to Footnote 6]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"[Continues from Footnote 5] such Out of the Money Option was not entitled to any payment of the Closing Amount in respect thereof and each Out of the Money Option was converted into the right to receive the CVR included in the Option Consideration with respect to each Share underlying such Out of the Money Option and became entitled to receive, at each time a milestone payment becomes due and payable under the terms of the CVR Agreement, an amount in cash equal to the product of (i) the number of Shares subject to such Out of the Money Option, and (ii) the amount, if any, by which (A) the Closing Amount plus the applicable milestone payment plus any other milestone payment that previously became due and payable under the terms of the CVR Agreement exceeds (B) the exercise price per Share with respect to such Out of the Money Option plus the amounts, [continues to Footnote 7]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"[Continues from Footnote 6] if any, paid to such Option holder with respect to such CVR in respect of any milestone payments that previously became due and payable under the terms of the CVR Agreement; provided further, that any Option with an exercise price that was equal to or greater than $20.50, was cancelled immediately prior to the effective time of the Merger without the receipt of any payment of the Closing Amount or CVR in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":32.5,"expiration_date":"2030-02-14","underlying":"Common Stock","underlying_shares":170000},"source":{"system":"sec-edgar","filing":"0001193125-25-259054","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000119312525259054/ownership.xml","form_type":"4"}},{"id":1011291,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-30T20:22:58.000Z","date":"2025-10-30","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":132242,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"As of immediately prior to and conditioned upon the occurrence of the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option to purchase Shares (each, an \"Option\") became fully vested and exercisable, and to the extent not exercised prior to the effective time of the Merger, was cancelled and converted into the right to receive (i) an amount in cash (without interest and subject to deduction for any required withholding taxes) equal to the product of (A) an amount equal to the excess of the Closing Amount over the exercise price per Share with respect to such Option and (B) the number of Shares subject to such Option plus (ii) one CVR with respect to each Share subject to such Option (the \"Option Consideration\"); provided, however, that if the exercise price per Share of any Option was equal to or greater than the Closing Amount, but less than $20.50 (any such option, an \"Out of the Money Option\"), [continues to Footnote 6]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"[Continues from Footnote 5] such Out of the Money Option was not entitled to any payment of the Closing Amount in respect thereof and each Out of the Money Option was converted into the right to receive the CVR included in the Option Consideration with respect to each Share underlying such Out of the Money Option and became entitled to receive, at each time a milestone payment becomes due and payable under the terms of the CVR Agreement, an amount in cash equal to the product of (i) the number of Shares subject to such Out of the Money Option, and (ii) the amount, if any, by which (A) the Closing Amount plus the applicable milestone payment plus any other milestone payment that previously became due and payable under the terms of the CVR Agreement exceeds (B) the exercise price per Share with respect to such Out of the Money Option plus the amounts, [continues to Footnote 7]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"[Continues from Footnote 6] if any, paid to such Option holder with respect to such CVR in respect of any milestone payments that previously became due and payable under the terms of the CVR Agreement; provided further, that any Option with an exercise price that was equal to or greater than $20.50, was cancelled immediately prior to the effective time of the Merger without the receipt of any payment of the Closing Amount or CVR in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":3.11,"expiration_date":"2029-07-30","underlying":"Common Stock","underlying_shares":132242},"source":{"system":"sec-edgar","filing":"0001193125-25-259054","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000119312525259054/ownership.xml","form_type":"4"}},{"id":1011290,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-30T20:22:58.000Z","date":"2025-10-30","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":120231,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"As of immediately prior to and conditioned upon the occurrence of the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option to purchase Shares (each, an \"Option\") became fully vested and exercisable, and to the extent not exercised prior to the effective time of the Merger, was cancelled and converted into the right to receive (i) an amount in cash (without interest and subject to deduction for any required withholding taxes) equal to the product of (A) an amount equal to the excess of the Closing Amount over the exercise price per Share with respect to such Option and (B) the number of Shares subject to such Option plus (ii) one CVR with respect to each Share subject to such Option (the \"Option Consideration\"); provided, however, that if the exercise price per Share of any Option was equal to or greater than the Closing Amount, but less than $20.50 (any such option, an \"Out of the Money Option\"), [continues to Footnote 6]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"[Continues from Footnote 5] such Out of the Money Option was not entitled to any payment of the Closing Amount in respect thereof and each Out of the Money Option was converted into the right to receive the CVR included in the Option Consideration with respect to each Share underlying such Out of the Money Option and became entitled to receive, at each time a milestone payment becomes due and payable under the terms of the CVR Agreement, an amount in cash equal to the product of (i) the number of Shares subject to such Out of the Money Option, and (ii) the amount, if any, by which (A) the Closing Amount plus the applicable milestone payment plus any other milestone payment that previously became due and payable under the terms of the CVR Agreement exceeds (B) the exercise price per Share with respect to such Out of the Money Option plus the amounts, [continues to Footnote 7]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"[Continues from Footnote 6] if any, paid to such Option holder with respect to such CVR in respect of any milestone payments that previously became due and payable under the terms of the CVR Agreement; provided further, that any Option with an exercise price that was equal to or greater than $20.50, was cancelled immediately prior to the effective time of the Merger without the receipt of any payment of the Closing Amount or CVR in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":1.93,"expiration_date":"2028-11-09","underlying":"Common Stock","underlying_shares":120231},"source":{"system":"sec-edgar","filing":"0001193125-25-259054","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000119312525259054/ownership.xml","form_type":"4"}},{"id":1011289,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-10-30T20:22:58.000Z","date":"2025-10-30","kind":"other","planned":false,"acquired":false,"shares":934273,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Disposed of pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of September 17, 2025, by and among 89bio, Inc. (the \"Issuer\"), Roche Holdings, Inc. (\"Parent\") and Bluefin Merger Subsidiary, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"). On October 30, 2025, Parent and Merger Sub completed a tender offer pursuant to the terms of the Merger Agreement for all outstanding shares of common stock of the Issuer (each, a \"Share\") for an offer price of (i) $14.50 per Share in cash, without interest (the \"Closing Amount\") less any required withholding taxes, plus (ii) one non-tradeable contingent value right (each, a \"CVR\") representing the right to receive certain contingent payments of up to an aggregate amount of $6.00 per Share, in cash, without interest less any required withholding taxes, upon the achievement of specified milestones on or prior to the applicable milestone outside dates, [continues to Footnote 4]"},{"field":"shares","element":"transactionShares","label":"F4","text":"[continues from Footnote 3] subject to and in accordance with the terms of the Contingent Value Rights Agreement (the \"CVR Agreement\") (the Closing Amount plus one CVR, collectively, the \"Offer Price\"). Merger Sub thereafter merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent (the \"Merger\"). At the effective time of the Merger, each issued and outstanding Share (other than any Excluded Shares (as such term is defined in the Merger Agreement)) was cancelled in exchange for the right to receive the Offer Price. In addition, as of immediately prior to and conditioned upon the occurrence of the effective time of the Merger, pursuant to the Merger Agreement, each outstanding restricted stock unit or performance-based restricted stock unit became fully vested and was cancelled in exchange for the right to receive the Offer Price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Disposed of pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of September 17, 2025, by and among 89bio, Inc. (the \"Issuer\"), Roche Holdings, Inc. (\"Parent\") and Bluefin Merger Subsidiary, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"). On October 30, 2025, Parent and Merger Sub completed a tender offer pursuant to the terms of the Merger Agreement for all outstanding shares of common stock of the Issuer (each, a \"Share\") for an offer price of (i) $14.50 per Share in cash, without interest (the \"Closing Amount\") less any required withholding taxes, plus (ii) one non-tradeable contingent value right (each, a \"CVR\") representing the right to receive certain contingent payments of up to an aggregate amount of $6.00 per Share, in cash, without interest less any required withholding taxes, upon the achievement of specified milestones on or prior to the applicable milestone outside dates, [continues to Footnote 4]"},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"[continues from Footnote 3] subject to and in accordance with the terms of the Contingent Value Rights Agreement (the \"CVR Agreement\") (the Closing Amount plus one CVR, collectively, the \"Offer Price\"). Merger Sub thereafter merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent (the \"Merger\"). At the effective time of the Merger, each issued and outstanding Share (other than any Excluded Shares (as such term is defined in the Merger Agreement)) was cancelled in exchange for the right to receive the Offer Price. In addition, as of immediately prior to and conditioned upon the occurrence of the effective time of the Merger, pursuant to the Merger Agreement, each outstanding restricted stock unit or performance-based restricted stock unit became fully vested and was cancelled in exchange for the right to receive the Offer Price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-25-259054","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000119312525259054/ownership.xml","form_type":"4"}},{"id":1011288,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-10-30T20:22:58.000Z","date":"2025-10-30","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents settlement by the Issuer of performance-based restricted stock units granted to the Reporting Person under the Company's Amended and Restated 2019 Equity Incentive Plan on September 9, 2022 and February 1, 2024, which vested as of immediately prior to and conditioned upon the occurrence of the effective time of the Merger (as defined below), pursuant to the Merger Agreement (as defined below)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents settlement by the Issuer of performance-based restricted stock units granted to the Reporting Person under the Company's Amended and Restated 2019 Equity Incentive Plan on September 9, 2022 and February 1, 2024, which vested as of immediately prior to and conditioned upon the occurrence of the effective time of the Merger (as defined below), pursuant to the Merger Agreement (as defined below)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 1,203 shares acquired by the Reporting Person under the Issuer's 2019 Employee Stock Purchase Plan on October 22, 2025."}],"balance_after":934273,"source":{"system":"sec-edgar","filing":"0001193125-25-259054","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000119312525259054/ownership.xml","form_type":"4"}},{"id":1074387,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-08-05T20:06:54.000Z","date":"2025-08-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":55836,"price":9.16,"value":511457.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld from the vesting of restricted stock units to cover the estimated tax withholding obligation."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 1,666 shares acquired by the Reporting Person under the Issuer's 2019 Employee Stock Purchase Plan on June 30, 2025."}],"balance_after":808070,"source":{"system":"sec-edgar","filing":"0000950170-25-103374","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000095017025103374/ownership.xml","form_type":"4"}},{"id":1111423,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-06-13T12:06:44.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":12050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/12 of the total shares monthly beginning July 12, 2025 until the option is fully vested on June 12, 2026, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":12050,"derivative":{"exercise_price":20.4,"expiration_date":"2035-06-12","underlying":"Common Stock","underlying_shares":12050},"source":{"system":"sec-edgar","filing":"0001404644-25-000066","document":"wk-form4_1749830797.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000140464425000066/wk-form4_1749830797.xml","form_type":"4"}},{"id":1259618,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-02-19T16:01:08.000Z","date":"2025-02-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":3249,"price":10.57,"value":34341.93,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld from the vesting of restricted stock units to cover the estimated tax withholding obligation."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 797 shares acquired by the Reporting Person under the Issuer's 2019 Employee Stock Purchase Plan on December 31, 2024."}],"balance_after":862240,"source":{"system":"sec-edgar","filing":"0000950170-25-023119","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000095017025023119/ownership.xml","form_type":"4"}},{"id":1273726,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-02-11T16:01:08.000Z","date":"2025-02-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":8946,"price":11.41,"value":102073.86,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld from the vesting of restricted stock units to cover the estimated tax withholding obligation."}],"balance_after":864692,"source":{"system":"sec-edgar","filing":"0000950170-25-017866","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000095017025017866/ownership.xml","form_type":"4"}},{"id":1284533,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-04T21:32:31.000Z","date":"2025-02-01","kind":"grant","planned":false,"acquired":true,"shares":848000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents a right to purchase a total of 848,000 shares of the Issuer's Common Stock, one quarter of which will vest on February 1, 2026, with the remaining three quarters vesting in equal quarterly installments over the following three years, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":848000,"derivative":{"exercise_price":9.6,"expiration_date":"2035-02-01","underlying":"Common Stock","underlying_shares":848000},"source":{"system":"sec-edgar","filing":"0000950170-25-014088","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000095017025014088/ownership.xml","form_type":"4"}},{"id":1284532,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-02-04T21:32:31.000Z","date":"2025-02-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":9598,"price":9.6,"value":92140.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These shares were withheld from the vesting of restricted stock units to cover the estimated tax withholding obligation."}],"balance_after":873638,"source":{"system":"sec-edgar","filing":"0000950170-25-014088","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000095017025014088/ownership.xml","form_type":"4"}},{"id":1284531,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-02-04T21:32:31.000Z","date":"2025-02-01","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents restricted stock units that vest in equal semi-annual installments over two years, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":883236,"source":{"system":"sec-edgar","filing":"0000950170-25-014088","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000095017025014088/ownership.xml","form_type":"4"}},{"id":1284530,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-02-04T21:32:31.000Z","date":"2025-02-01","kind":"grant","planned":false,"acquired":true,"shares":212000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units that vest in equal semi-annual installments over three years, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":683236,"source":{"system":"sec-edgar","filing":"0000950170-25-014088","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000095017025014088/ownership.xml","form_type":"4"}},{"id":1337078,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-12-10T06:02:26.000Z","date":"2024-12-06","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":7.89,"value":39450.0,"ownership":{"direct":true},"balance_after":471236,"source":{"system":"sec-edgar","filing":"0000950170-24-134750","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000095017024134750/ownership.xml","form_type":"4"}},{"id":1352563,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-11-25T06:05:30.000Z","date":"2024-11-22","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":8.35,"value":83500.0,"ownership":{"direct":true},"balance_after":466236,"source":{"system":"sec-edgar","filing":"0000950170-24-130418","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000095017024130418/ownership.xml","form_type":"4"}},{"id":1429167,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-08-19T17:29:17.000Z","date":"2024-08-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":4601,"price":8.04,"value":36992.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld from the vesting of restricted stock units to cover the estimated tax withholding obligation."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 1,666 shares acquired by the Reporting Person under the Issuer's 2019 Employee Stock Purchase Plan on June 28, 2024."}],"balance_after":456236,"source":{"system":"sec-edgar","filing":"0000950170-24-098698","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000095017024098698/ownership.xml","form_type":"4"}},{"id":1477170,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-17T14:37:01.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":7700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase 7,700 shares of the Issuer's common stock, which will vest in its entirety on the earlier of (a) the first anniversary of the date of grant or (b) the date of the Issuer's 2025 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer through such applicable vesting date."}],"balance_after":7700,"derivative":{"exercise_price":42.59,"expiration_date":"2034-06-14","underlying":"Common Stock","underlying_shares":7700},"source":{"system":"sec-edgar","filing":"0001404644-24-000070","document":"wk-form4_1718649414.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000140464424000070/wk-form4_1718649414.xml","form_type":"4"}},{"id":1549267,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-03T16:01:07.000Z","date":"2024-04-01","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is vested in full."}],"balance_after":120231,"derivative":{"exercise_price":1.93,"expiration_date":"2028-11-09","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000950170-24-041024","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000095017024041024/ownership.xml","form_type":"4"}},{"id":1549266,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-04-03T16:01:07.000Z","date":"2024-04-01","kind":"sale","planned":true,"acquired":false,"shares":52718,"price":10.91,"value":575153.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on July 5, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $10.65 to $11.54. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."}],"balance_after":459171,"source":{"system":"sec-edgar","filing":"0000950170-24-041024","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000095017024041024/ownership.xml","form_type":"4"}},{"id":1549265,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-04-03T16:01:07.000Z","date":"2024-04-01","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":1.93,"value":48250.0,"ownership":{"direct":true},"balance_after":511889,"source":{"system":"sec-edgar","filing":"0000950170-24-041024","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000095017024041024/ownership.xml","form_type":"4"}},{"id":1612074,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-02-28T18:43:17.000Z","date":"2024-02-26","kind":"sale","planned":true,"acquired":false,"shares":4477,"price":10.76,"value":48172.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on July 5, 2023."}],"balance_after":486889,"source":{"system":"sec-edgar","filing":"0000950170-24-022433","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000095017024022433/ownership.xml","form_type":"4"}},{"id":1622354,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-02-23T20:51:53.000Z","date":"2024-02-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":4602,"price":9.74,"value":44823.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld from the vesting of restricted stock units to cover the estimated tax withholding obligation."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Due to an administrative error, the exercise of an aggregate of 15,000 options was erroneously omitted from the Form 4 filed by the Reporting Person on March 27, 2023. This form reflects the correct amount of common stock owned by the Reporting Person. The exercise of an aggregate of 15,000 options was reported in Table II on  the Form 4 filed by the Reporting Person on June 7, 2023."}],"balance_after":491366,"source":{"system":"sec-edgar","filing":"0000950170-24-019662","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000095017024019662/ownership.xml","form_type":"4"}},{"id":1645922,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-02-13T20:58:14.000Z","date":"2024-02-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":12670,"price":8.45,"value":107061.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld from the vesting of restricted stock units to cover the estimated tax withholding obligation."}],"balance_after":480968,"source":{"system":"sec-edgar","filing":"0000950170-24-014886","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000095017024014886/ownership.xml","form_type":"4"}},{"id":1658628,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-05T20:16:12.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":605000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option represents a right to purchase a total of 605,000 shares of the Issuer's Common Stock, one quarter of which will vest on February 1, 2025, with the remaining three quarters vesting in equal quarterly installments over the following three years, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":605000,"derivative":{"exercise_price":9.98,"expiration_date":"2034-02-01","underlying":"Common Stock","underlying_shares":605000},"source":{"system":"sec-edgar","filing":"0000950170-24-011475","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000095017024011475/ownership.xml","form_type":"4"}},{"id":1658627,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-02-05T20:16:12.000Z","date":"2024-02-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":5068,"price":9.8,"value":49666.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were withheld from the vesting of a performance-based RSU award to cover the estimated tax withholding obligation."}],"balance_after":493646,"source":{"system":"sec-edgar","filing":"0000950170-24-011475","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000095017024011475/ownership.xml","form_type":"4"}},{"id":1658626,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-02-05T20:16:12.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (\"RSUs\") that vest in equal semi-annual installments over three years, subject to the Reporting Person's continued service to the Issuer."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") that vest in equal semi-annual installments over three years, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":498714,"source":{"system":"sec-edgar","filing":"0000950170-24-011475","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000095017024011475/ownership.xml","form_type":"4"}},{"id":1676254,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-18T18:58:27.000Z","date":"2024-01-16","kind":"grant","planned":false,"acquired":true,"shares":15400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents the right to purchase 15,400 shares of common stock of the Issuer, and vests in equal monthly installments through January 16, 2027, subject to the reporting person's continued service to the Issuer through each applicable vesting date."}],"balance_after":15400,"derivative":{"exercise_price":32.3,"expiration_date":"2034-01-16","underlying":"Common Stock","underlying_shares":15400},"source":{"system":"sec-edgar","filing":"0000950170-24-005539","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000095017024005539/ownership.xml","form_type":"4"}},{"id":1684079,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-01-08T18:31:58.000Z","date":"2024-01-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":27511,"price":11.53,"value":317201.83,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were withheld from the vesting of a performance-based RSU award to cover the estimated tax withholding obligation."}],"balance_after":348714,"source":{"system":"sec-edgar","filing":"0000950170-24-003105","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000095017024003105/ownership.xml","form_type":"4"}},{"id":1684078,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-01-08T18:31:58.000Z","date":"2024-01-05","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents settlement by the Issuer of performance-based restricted stock units (\"RSUs\") granted to the Reporting Person under the Company's Amended and Restated 2019 Equity Incentive Plan on September 9, 2022, which vested based on the Issuer's achievement of corporate performance objectives."}],"balance_after":376225,"source":{"system":"sec-edgar","filing":"0000950170-24-003105","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000095017024003105/ownership.xml","form_type":"4"}},{"id":1691961,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-03T16:54:23.000Z","date":"2023-12-29","kind":"exercise","planned":true,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option is vested in full."}],"balance_after":145231,"derivative":{"exercise_price":1.93,"expiration_date":"2028-11-09","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000950170-24-001035","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000095017024001035/ownership.xml","form_type":"4"}},{"id":1691960,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-01-03T16:54:23.000Z","date":"2023-12-29","kind":"sale","planned":true,"acquired":false,"shares":50000,"price":11.2,"value":560000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on July 5, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $11.035 to $11.33. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."}],"balance_after":301225,"source":{"system":"sec-edgar","filing":"0000950170-24-001035","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000095017024001035/ownership.xml","form_type":"4"}},{"id":1691959,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-01-03T16:54:23.000Z","date":"2023-12-29","kind":"exercise","planned":true,"acquired":true,"shares":50000,"price":1.93,"value":96500.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 275 shares acquired by the Reporting Person under the Issuer's 2019 Employee Stock Purchase Plan on December 31, 2023."}],"balance_after":351225,"source":{"system":"sec-edgar","filing":"0000950170-24-001035","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000095017024001035/ownership.xml","form_type":"4"}},{"id":1800658,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-08-21T17:49:09.000Z","date":"2023-08-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":4501,"price":15.46,"value":69585.46,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld from the vesting of restricted stock units to cover the estimated tax withholding obligation."}],"balance_after":300950,"source":{"system":"sec-edgar","filing":"0000899243-23-018332","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000089924323018332/doc4.xml","form_type":"4"}},{"id":1835901,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-07-05T20:39:04.000Z","date":"2023-06-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":16527,"price":18.95,"value":313186.65,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These shares were withheld from the vesting of a performance-based RSU award to cover the estimated tax withholding obligation."}],"balance_after":305451,"source":{"system":"sec-edgar","filing":"0000950170-23-031839","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000095017023031839/ownership.xml","form_type":"4"}},{"id":1835900,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-07-05T20:39:04.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":33334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents settlement by the Issuer of performance-based restricted stock units (\"RSUs\") granted to the Reporting Person under the Issuer's Amended and Restated 2019 Equity Incentive Plan on February 17, 2022, which vested based on the Issuer's achievement of corporate performance objectives."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 1,666 shares acquired by the Reporting Person under the Issuer's 2019 Employee Stock Purchase Plan on June 30, 2023."}],"balance_after":321978,"source":{"system":"sec-edgar","filing":"0000950170-23-031839","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000095017023031839/ownership.xml","form_type":"4"}},{"id":1860393,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-09T16:27:28.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/12 of the total shares monthly beginning July 8, 2023 until the option is fully vested on June 8, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":25000,"derivative":{"exercise_price":0.79,"expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-23-035866","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000120919123035866/doc4.xml","form_type":"4"}},{"id":1863762,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-07T17:04:21.000Z","date":"2023-06-05","kind":"exercise","planned":false,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is vested in full."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Due to an administrative error, the exercise of an aggregate of 15,000 options was erroneously omitted from the Form 4 filed by the Reporting Person on March 27, 2023. This form reflects the correct amount of stock options owned by the Reporting Person."}],"balance_after":195231,"derivative":{"exercise_price":1.93,"expiration_date":"2028-11-09","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000950170-23-026845","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000095017023026845/ownership.xml","form_type":"4"}},{"id":1863761,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-06-07T17:04:21.000Z","date":"2023-06-05","kind":"sale","planned":false,"acquired":false,"shares":15000,"price":20,"value":300000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on November 15, 2022."}],"balance_after":286978,"source":{"system":"sec-edgar","filing":"0000950170-23-026845","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000095017023026845/ownership.xml","form_type":"4"}},{"id":1863760,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-06-07T17:04:21.000Z","date":"2023-06-05","kind":"exercise","planned":false,"acquired":true,"shares":15000,"price":1.93,"value":28950.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 8 shares acquired by the Reporting Person under the Issuer's 2019 Employee Stock Purchase Plan on December 30, 2022."}],"balance_after":301978,"source":{"system":"sec-edgar","filing":"0000950170-23-026845","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000095017023026845/ownership.xml","form_type":"4"}},{"id":1927784,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-04-04T16:18:01.000Z","date":"2023-03-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":15443,"price":15.23,"value":235196.89,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were withheld from the vesting of a performance-based RSU award to cover the estimated tax withholding obligation."}],"balance_after":286970,"source":{"system":"sec-edgar","filing":"0000899243-23-010403","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000089924323010403/doc4.xml","form_type":"4"}},{"id":1927783,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-04-04T16:18:01.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":33333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents settlement by the Issuer of performance-based restricted stock units (\"RSUs\") granted to the Reporting Person under the Company's Amended and Restated 2019 Equity Incentive Plan on February 17, 2022, which vested based on the Issuer's achievement of corporate performance objectives."}],"balance_after":302413,"source":{"system":"sec-edgar","filing":"0000899243-23-010403","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000089924323010403/doc4.xml","form_type":"4"}},{"id":1937825,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-03-27T19:18:38.000Z","date":"2023-03-23","kind":"sale","planned":false,"acquired":false,"shares":15000,"price":16,"value":240000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on November 15, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 8 shares acquired by the Reporting Person under the Issuer's 2019 Employee Stock Purchase Plan on December 30, 2022."}],"balance_after":269080,"source":{"system":"sec-edgar","filing":"0000950170-23-010075","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000095017023010075/ownership.xml","form_type":"4"}},{"id":1999580,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-02-22T18:38:59.000Z","date":"2023-02-17","kind":"tax_withholding","acquired":false,"shares":6279,"price":13.97,"value":87717.63,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the release of 17,886 restricted stock units on February 17, 2023."}],"balance_after":284072,"source":{"system":"sec-edgar","filing":"0000899243-23-005875","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000089924323005875/doc4.xml","form_type":"4"}},{"id":2019807,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-13T17:42:41.000Z","date":"2023-02-09","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents a right to purchase a total of 300,000 shares of the Issuer's Common Stock, one quarter of which will vest on February 9, 2024, with the remaining three quarters vesting in equal quarterly installments over the following three years, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":300000,"derivative":{"exercise_price":14.7,"expiration_date":"2033-02-09","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0000899243-23-004813","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000089924323004813/doc4.xml","form_type":"4"}},{"id":2019806,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-02-13T17:42:41.000Z","date":"2023-02-09","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units that vest with respect to one-third of the underlying shares on February 9, 2024, with the remaining two-thirds vesting in equal semi-annual installments over the following two years, subject to the Reporting Person's continued service to the Issuer."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest with respect to one-third of the underlying shares on February 9, 2024, with the remaining two-thirds vesting in equal semi-annual installments over the following two years, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":290351,"source":{"system":"sec-edgar","filing":"0000899243-23-004813","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000089924323004813/doc4.xml","form_type":"4"}},{"id":2028291,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-02-07T19:36:17.000Z","date":"2023-02-05","kind":"tax_withholding","acquired":false,"shares":4078,"price":13.24,"value":53992.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the release of 10,000 performance stock units on February 5, 2023."}],"balance_after":215351,"source":{"system":"sec-edgar","filing":"0000899243-23-004245","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000089924323004245/doc4.xml","form_type":"4"}},{"id":2148636,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-09-30T19:02:27.000Z","date":"2022-09-28","kind":"tax_withholding","acquired":false,"shares":11527,"price":5.76,"value":66395.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were withheld from the vesting of a performance-based RSU award to cover the estimated tax withholding obligation."}],"balance_after":219429,"source":{"system":"sec-edgar","filing":"0000899243-22-032337","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000089924322032337/doc4.xml","form_type":"4"}},{"id":2148635,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-09-30T19:02:27.000Z","date":"2022-09-28","kind":"grant","acquired":true,"shares":33333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents settlement by the Issuer of performance-based restricted stock units (\"RSUs\") granted to the Reporting Person under the Company's Amended and Restated 2019 Equity Incentive Plan on February 17, 2022, which vested based on the Issuer's achievement of corporate performance objectives."}],"balance_after":230956,"source":{"system":"sec-edgar","filing":"0000899243-22-032337","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000089924322032337/doc4.xml","form_type":"4"}},{"id":2162208,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-09-09T16:39:18.000Z","date":"2022-09-08","kind":"exercise","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is vested in full."}],"balance_after":225231,"derivative":{"exercise_price":1.93,"expiration_date":"2028-11-09","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-22-030733","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000089924322030733/doc4.xml","form_type":"4"}},{"id":2162207,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-09-09T16:39:18.000Z","date":"2022-09-08","kind":"exercise","acquired":true,"shares":100000,"price":1.93,"value":193000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 1,666 shares acquired by the Reporting Person under the Issuer's 2019 Employee Stock Purchase Plan on June 30, 2022."}],"balance_after":197623,"source":{"system":"sec-edgar","filing":"0000899243-22-030733","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000089924322030733/doc4.xml","form_type":"4"}},{"id":2270201,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-16T18:26:13.000Z","date":"2022-05-12","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/12 of the total shares monthly beginning June 12, 2022 until the option is fully vested on May 12, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":25000,"derivative":{"exercise_price":1.07,"expiration_date":"2032-05-11","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-22-029325","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000120919122029325/doc4.xml","form_type":"4"}},{"id":2297656,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-04-13T16:05:14.000Z","date":"2022-02-05","kind":"tax_withholding","acquired":false,"shares":4088,"price":5.23,"value":21380.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the release of 10,000 performance stock units on February 5, 2022."}],"balance_after":95957,"source":{"system":"sec-edgar","filing":"0000899243-22-014688","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000089924322014688/doc4.xml","form_type":"4"}},{"id":2350110,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-04T18:12:25.000Z","date":"2022-03-02","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/3 of the total shares on each of March 2, 2023, March 2, 2024 and March 2, 2025, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":50000,"derivative":{"exercise_price":2.72,"expiration_date":"2032-03-01","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-22-016454","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000120919122016454/doc4.xml","form_type":"4"}},{"id":2382060,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-22T17:06:56.000Z","date":"2022-02-17","kind":"grant","acquired":true,"shares":220000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents a right to purchase a total of 220,000 shares of the Issuer's Common Stock, one quarter of which will vest on February 17, 2023, with the remaining three quarters vesting in equal quarterly installments over the following three years, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":220000,"derivative":{"exercise_price":4.44,"expiration_date":"2032-02-16","underlying":"Common Stock","underlying_shares":220000},"source":{"system":"sec-edgar","filing":"0000899243-22-007224","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000089924322007224/doc4.xml","form_type":"4"}},{"id":2382059,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-02-22T17:06:56.000Z","date":"2022-02-17","kind":"grant","acquired":true,"shares":54200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units that vest with respect to one-third of the underlying shares on February 17, 2023, with the remaining two-thirds vesting in equal semi-annual installments over the following two years, subject to the Reporting Person's continued service to the Issuer."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest with respect to one-third of the underlying shares on February 17, 2023, with the remaining two-thirds vesting in equal semi-annual installments over the following two years, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":100045,"source":{"system":"sec-edgar","filing":"0000899243-22-007224","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000089924322007224/doc4.xml","form_type":"4"}},{"id":2421049,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-01-31T16:30:44.000Z","date":"2022-01-28","kind":"purchase","acquired":true,"shares":2500,"price":6.14,"value":15350.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 1,345 shares acquired by the Reporting Person under the Issuer's 2019 Employee Stock Purchase Plan on January 1, 2022."}],"balance_after":45845,"source":{"system":"sec-edgar","filing":"0000899243-22-003651","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000089924322003651/doc4.xml","form_type":"4"}},{"id":2421048,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-01-31T16:30:44.000Z","date":"2022-01-27","kind":"purchase","acquired":true,"shares":5000,"price":7.5,"value":37500.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 1,345 shares acquired by the Reporting Person under the Issuer's 2019 Employee Stock Purchase Plan on January 1, 2022."}],"balance_after":43345,"source":{"system":"sec-edgar","filing":"0000899243-22-003651","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000089924322003651/doc4.xml","form_type":"4"}},{"id":2637987,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-07-08T16:05:18.000Z","date":"2021-07-08","kind":"purchase","acquired":true,"shares":2000,"price":16.25,"value":32500.0,"ownership":{"direct":true},"balance_after":37000,"source":{"system":"sec-edgar","filing":"0000899243-21-027876","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000089924321027876/doc4.xml","form_type":"4"}},{"id":2637986,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-07-08T16:05:18.000Z","date":"2021-07-07","kind":"purchase","acquired":true,"shares":5000,"price":17.07,"value":85350.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.00 to $17.12 inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range."}],"balance_after":35000,"source":{"system":"sec-edgar","filing":"0000899243-21-027876","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000089924321027876/doc4.xml","form_type":"4"}},{"id":2871677,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-09T16:55:16.000Z","date":"2021-02-05","kind":"grant","acquired":true,"shares":203750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents a right to purchase a total of 203,750 shares of the Issuer's Common Stock, one quarter of which will vest on February 5, 2022, with the remaining three quarters vesting in equal quarterly installments over the following three years, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":203750,"derivative":{"exercise_price":23.01,"expiration_date":"2031-02-05","underlying":"Common Stock","underlying_shares":203750},"source":{"system":"sec-edgar","filing":"0000899243-21-005468","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000089924321005468/doc4.xml","form_type":"4"}},{"id":2871676,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-02-09T16:55:16.000Z","date":"2021-02-05","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Performance stock units vest with respect to 30,000 shares in three equal installments on the first, second and third anniversaries of February 5, 2021, subject to the achievement of specified milestone events and the Reporting Person's continued service to the Issuer."},{"field":"shares","element":"transactionShares","label":"F1","text":"Performance stock units vest with respect to 30,000 shares in three equal installments on the first, second and third anniversaries of February 5, 2021, subject to the achievement of specified milestone events and the Reporting Person's continued service to the Issuer."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0000899243-21-005468","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000089924321005468/doc4.xml","form_type":"4"}},{"id":3262820,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":64921,"kind":"person","name":"PALEKAR ROHAN","position":1,"cik":"0001423327","reported_name":"PALEKAR ROHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-19T18:01:22.000Z","date":"2020-02-14","kind":"grant","acquired":true,"shares":170000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 170,000 shares of the Issuer's Common Stock, one quarter of which will vest on February 14, 2021, with the remaining three quarters vesting in equal quarterly installments over the following three years."}],"balance_after":170000,"derivative":{"exercise_price":32.5,"expiration_date":"2030-02-14","underlying":"Common Stock","underlying_shares":170000},"source":{"system":"sec-edgar","filing":"0000899243-20-005092","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423327/000089924320005092/doc4.xml","form_type":"4"}}]}